Dr Michael Baker, CEO and MD, shared Arovella’s story with Henry Jennings on the Marcus Today podcast. Dr Baker discussed Arovella’s iNKT cell therapy, an “off-the-shelf” approach that tackles blood cancers with better cost efficiency.
Dr Michael Baker interviewed on the Marcus Today podcast
Previous
Previous
MST Access analyst coverage
Next
Next